The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development

[1]  G. Ball,et al.  Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion. , 2022, American journal of cancer research.

[2]  Jinfang Jiang,et al.  CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis , 2019, BMC Medical Genomics.

[3]  Ya-zhuo Zhang,et al.  Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial-to-mesenchymal transition , 2019, Oncology letters.

[4]  Farid Zayeri,et al.  Global Trend of Breast Cancer Mortality Rate: A 25-Year Study , 2019, Asian Pacific journal of cancer prevention : APJCP.

[5]  Juan Li,et al.  MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1 , 2019, Cancer Cell International.

[6]  S. Tai,et al.  Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization , 2018, Nature Communications.

[7]  A. Schneeweiss,et al.  Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis , 2018, EMBO molecular medicine.

[8]  Michael K. Wendt,et al.  Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer , 2018, Breast Cancer Research.

[9]  I. Ellis,et al.  Diagnostic concordance of reporting lymphovascular invasion in breast cancer , 2018, Journal of Clinical Pathology.

[10]  G. Shao,et al.  Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis , 2018, Technology in cancer research & treatment.

[11]  K. He,et al.  Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers , 2017, Medicine.

[12]  R. Hass,et al.  Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites , 2017, BioMed research international.

[13]  Ying Chai,et al.  Prognostic role of cyclin B1 in solid tumors: a meta-analysis , 2016, Oncotarget.

[14]  G. Ball,et al.  SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. , 2016, The Lancet. Oncology.

[15]  R. Aebersold,et al.  On the Dependency of Cellular Protein Levels on mRNA Abundance , 2016, Cell.

[16]  Steven J. M. Jones,et al.  Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer , 2015, Cell.

[17]  A. Mukherjee,et al.  Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer , 2015, Pathobiology.

[18]  C. D. Savci-Heijink,et al.  Retrospective analysis of metastatic behaviour of breast cancer subtypes , 2015, Breast Cancer Research and Treatment.

[19]  D. Carraro,et al.  Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast , 2014, Tumor Biology.

[20]  Weixun Zhou,et al.  The prognostic value of Cyclin B1 in pancreatic cancer , 2014, Medical Oncology.

[21]  X. Liang,et al.  Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer , 2014, Cancer biology & therapy.

[22]  Yongxiang Yin,et al.  The Levels of Ki-67 Positive are Positively Associated with Lymph Node Metastasis in Invasive Ductal Breast Cancer , 2014, Cell Biochemistry and Biophysics.

[23]  Zhiming Zhang,et al.  Expression and Clinical Significance of Matrix Metalloproteinase-9 in Lymphatic Invasiveness and Metastasis of Breast Cancer , 2014, PloS one.

[24]  Ju-Seog Lee,et al.  Expression Signature Defined by FOXM1–CCNB1 Activation Predicts Disease Recurrence in Non–Muscle-Invasive Bladder Cancer , 2014, Clinical Cancer Research.

[25]  S. Stacker,et al.  Lymphangiogenesis and lymphatic vessel remodelling in cancer , 2014, Nature Reviews Cancer.

[26]  J. Behr,et al.  Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases , 2013, BMC Cancer.

[27]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[28]  I. Ellis,et al.  The prognostic significance of lymphovascular invasion in invasive breast carcinoma , 2012, Cancer.

[29]  J. K. Lee,et al.  Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor , 2012, Tumor Biology.

[30]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[31]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[32]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[33]  Li Weng,et al.  Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection , 2012, Molecular Cancer.

[34]  I. Ellis,et al.  Tumour-infiltrating macrophages and clinical outcome in breast cancer , 2011, Journal of Clinical Pathology.

[35]  M. Park,et al.  The Role of Lymphovascular Invasion as a Prognostic Factor in Patients with Lymph Node-Positive Operable Invasive Breast Cancer , 2011, Journal of breast cancer.

[36]  I. Ellis,et al.  Objective assessment of lymphatic and blood vascular invasion in lymph node‐negative breast carcinoma: findings from a large case series with long‐term follow‐up , 2011, The Journal of pathology.

[37]  I. Ellis,et al.  An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer , 2011, Breast Cancer Research and Treatment.

[38]  I. Lavrik,et al.  Cdk1/Cyclin B1 Controls Fas-Mediated Apoptosis by Regulating Caspase-8 Activity , 2010, Molecular and Cellular Biology.

[39]  L. Holmberg,et al.  Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort , 2010, International journal of cancer.

[40]  J. Fregnani,et al.  Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication. , 2010, Human pathology.

[41]  I. Ellis,et al.  Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes , 2009, Clinical Cancer Research.

[42]  Q. Zhan,et al.  Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. , 2008, Carcinogenesis.

[43]  I. Ellis,et al.  Expression profiling technology: its contribution to our understanding of breast cancer , 2007, Histopathology.

[44]  C. Perez-stable,et al.  Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy , 2007, Molecular Cancer Therapeutics.

[45]  K. Wakasa,et al.  Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients. , 2007, Oncology reports.

[46]  G. Christofori.  New signals from the invasive front , 2006, Nature.

[47]  M. Pagano,et al.  Stabilizers and destabilizers controlling cell cycle oscillators. , 2006, Molecular cell.

[48]  G. Ball,et al.  High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.

[49]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[50]  D G Altman,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British journal of cancer.

[51]  S. Pinder,et al.  E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significance , 2005, Histopathology.

[52]  P. Hinds,et al.  Cyclins and cdks in development and cancer: a perspective , 2005, Oncogene.

[53]  S. Eccles,et al.  Breast cancer metastasis: when, where, how? , 2005, The Lancet.

[54]  I. Ellis,et al.  Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma , 2004, British Journal of Cancer.

[55]  H. Grabsch,et al.  Prognostic value of cyclin B1 protein expression in colorectal cancer. , 2004, American journal of clinical pathology.

[56]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[57]  M. Lippman,et al.  Breast Cancer Research and Treatment , 2004, Breast Cancer Research and Treatment.

[58]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[59]  D. Ribnikar,et al.  Metastatic breast cancer. , 2014, Current opinion in oncology.

[60]  A. Harris,et al.  Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis. , 2001, European journal of cancer.

[61]  F. Khuri,et al.  Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. , 2000, Cancer research.

[62]  G. Stark,et al.  Mechanisms of G2 arrest in response to overexpression of p53. , 1999, Molecular biology of the cell.

[63]  J. M. Lee,et al.  p53 regulates a G2 checkpoint through cyclin B1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  E. Nishida,et al.  Nuclear export of cyclin B1 and its possible role in the DNA damage‐induced G2 checkpoint , 1998, The EMBO journal.

[65]  H. Koizumi,et al.  Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. , 1997, The American journal of pathology.

[66]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[67]  柿野 俊介.  Intracellular localization of cyclin B1 during the cell cycle in glioma cells , 1996 .

[68]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[69]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[70]  T. Hunter,et al.  Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport , 1991, The Journal of cell biology.

[71]  K. Mccarty,et al.  Histochemical approaches to steroid receptor analyses. , 1984, Seminars in diagnostic pathology.

[72]  A. Patchefsky,et al.  Interobserver variation in the identification of breast carcinoma in intramammary lymphatics. , 1982, Human pathology.